Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01788514
Other study ID # 11028
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2013
Est. completion date May 2014

Study information

Verified date February 2019
Source New York University School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators have developed an influenza-vaccination-education-study-program that will involve the use of an animated influenza vaccine-based computer program (videogame) that is designed from the investigator's own initiative. The investigators propose implementing an influenza vaccination educational program in the pediatric satellite office that serves a population that has historical low rates of influenza vaccination.


Description:

Each year, during the fall and winter, coinciding with the influenza season, the number of health care visits and the number of days missed from school increases due to febrile respiratory illnesses. The highest rates of influenza infections are present amongst school-age children. The vaccination against seasonal influenza remains the most important measure to prevent infection and to combat the overall spread of the virus. School-age children, in particular, adolescents, may not be aware of the need for influenza vaccination.

Interactive computerized educational programs have been developed and used in different pediatric settings in an attempt to increase children's understanding of their medical condition, and improve adherence to the treatment.

The investigators identified one of our satellite pediatric clinics, as being the perfect venue for an intervention that will attempt to increase influenza vaccination. The clinic is located in an underserved area. More than 9,000 children are seen annually in this clinic with about 20% of the patients age 8 and above. A pediatric pulmonary office, part of the pediatric clinic, serves a high number of patients, most of whom have poorly controlled asthma.

Currently, no focused, developmentally appropriate education programs regarding vaccination are used in our outpatient clinics.

The investigators propose implementing an influenza vaccination educational program in this pediatric satellite office that serves a population that has historical low rates of influenza vaccination.

The investigators have developed an influenza-vaccination-education-study-program that will involve the use of an animated influenza vaccine-based computer program (videogame) that is designed from the investigator's own initiative. This videogame should provide a basis or foundation to discuss the need for influenza vaccination and the adverse effects of influenza disease. It will be designed to intrigue the child by providing animated tours and creative experiences that are designed to encourage behavioral changes towards the need for vaccination.

The investigators hypothesis that by using this hybrid entertainment-educational tool, we will increase children's knowledge about influenza disease and the need for influenza vaccination. By using this age appropriate intervention, we aim to decrease children and adolescent's anxiety related to the vaccination and to increase vaccination rates. The investigators hypothesis that our intervention will have a high impact since it is geared to an ethnic community with historically low rates of influenza vaccination.


Recruitment information / eligibility

Status Completed
Enrollment 51
Est. completion date May 2014
Est. primary completion date May 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 8 Years to 17 Years
Eligibility Inclusion Criteria:

- Children 8 years of age and older

Exclusion Criteria:

- Anyone who does not voluntarily give consent or assent to this study.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Videogame
Subject will play an interactive educational videogame that is designed to increase their knowledge on influenza and the influenza vaccination.

Locations

Country Name City State
United States Winthrop University Hospital Mineola New York

Sponsors (1)

Lead Sponsor Collaborator
New York University School of Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Increase the knowledge regarding influenza infection and influenza vaccination in school-age children and adolescents. Subjects will be given a pre-intervention questionnaire to assess their basic knowledge about influenza infection. Subjects then will play a videogame, designed to be an entertainment-educational hybrid product on influenza infection and influenza vaccination subject. After the intervention, subjects will fill out a post-intervention questionnaire that will assess their knowledge about influenza infection and vaccination. 7 months
Secondary Increase influenza vaccination in school-age children and adolescents using an entertainment-educational videogame product. We will assess how many subjects chose to receive the influenza vaccination after playing the educational interactive videogame. 7 months
See also
  Status Clinical Trial Phase
Completed NCT05523089 - The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults Phase 2
Completed NCT05009251 - Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake N/A
Completed NCT03282240 - Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US Phase 3
Completed NCT00968539 - Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults Phase 3
Completed NCT00968526 - Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults Phase 3
Completed NCT00971425 - Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1) Phase 3
Completed NCT05525494 - Patient Portal Flu Vaccine Reminders (5) N/A
Completed NCT04074928 - Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects Phase 3
Completed NCT04695717 - This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam Phase 3
Completed NCT05012163 - Lottery Incentive Nudges to Increase Influenza Vaccinations N/A
Completed NCT03888989 - Response to Influenza Vaccine During Pregnancy Phase 1
Completed NCT04109222 - Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively Phase 4
Completed NCT02587221 - Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age Phase 3
Completed NCT03453801 - The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection Phase 1
Completed NCT01440387 - A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older Phase 3
Terminated NCT01195779 - Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children Phase 2
Completed NCT03321968 - Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults Phase 3
Completed NCT00972517 - Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children Phase 3
Completed NCT04570904 - Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness
Recruiting NCT03331991 - Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel N/A